Franco Marincola - Concepedia

Author

Franco Marincola

Also Known As

Ena Wang, F M Marincola, F. M. Marincola, F. Marincola, F.M. Marincola, Francesco M. Marincola, Franco M Marincola, Franco M. Marincola, Franco Marincola, Marincola, Franco

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institutes of Health Clinical Center National Cancer Institute Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Massachusetts General Hospital

About

Franco Marincola is an author at National Institutes of Health specializing in immunology, immunotherapy, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	8	696
2	Immunology	7	8	696
3	Cell Biology	3	3	383
4	Public Health	1	1	176
5	Gastroenterology	1	1	86

Franco Marincola

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy Nicholas P. Restifo, Franco Marincola, Yutaka Kawakami, JNCI Journal of the National Cancer Institute	1996	528
Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities Nicole Frahm, Bette Korber, Craig Adams, Journal of Virology	2004	274
Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35). Douglas J. Loftus, Chiara Castelli, Timothy M. Clay, The Journal of Experimental Medicine ImmunologyPathologyAntigen ProcessingPeptide ScienceImmunotherapy	1996	181
Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7. Michael A. Steller, Karen J. Gurski, Masaru Murakami, PubMed ImmunologyImmunoeditingPathologyLipidated EpitopeImmunotherapy	1998	176
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. Franco Marincola, Peter Shamamian, Richard B. Alexander, The Journal of Immunology HistocompatibilityGeneticsImmunologyMolecular GeneticsImmunotherapy	1994	168
Real-Time Quantitative Polymerase Chain Reaction Assessment of Immune Reactivity in Melanoma Patients After Tumor Peptide Vaccination Udai S. Kammula, Franco Marincola, Steven A. Rosenberg JNCI Journal of the National Cancer Institute	2000	101
Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients. Jérôme Galon, Bernhard Mlecnik, Florence Marliot, Journal of Clinical Oncology ImmunologyGastroenterologyPathologyImmunotherapyPrognostic Marker	2016	86
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy Licia Rivoltini, Douglas J. Loftus, Kathleen C. Barracchini, The Journal of Immunology	1996	78
Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma. Richard E. Royal, Seth M. Steinberg, Robert S. Krouse, PubMed	2006	71
Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation Luigi Buonaguro, Alessandro Monaco, Eleonora Aricò, BMC Bioinformatics	2008	40

Page 1